Revisado por Isabelle Baião de Mello Neto (CRF-MG 24309)Dizeres Legais do Triatec D
Venda sob prescrição médica.
| Registros MS | |
30 comprimidos | M.S 1.1300.0159.005-0 |
M.S 1.1300.0159.007-7 | |
M.S 1.1300.0159.010-7 | |
M.S 1.1300.0159.014-1 | |
20 comprimidos | M.S 1.1300.0159.006-9 |
M.S 1.1300.0159.008-5 | |
M.S 1.1300.0159.009-3 | |
M.S 1.1300.0159.013-1 | |
15 comprimidos | M.S 1.1300.0159.011-5 |
M.S 1.1300.0159.012-3 | |
Farm. Resp.:
Antonia A. Oliveira
CRF-SP nº 5854
Fabricado por:
Sanofi-Aventis S.p.A.
Strada Statale 17 – Km 22
67019 – Scoppito - Itália
Importado e Embalado por:
Sanofi-Aventis Farmacêutica Ltda.
Rua Conde Domingos Papais, 413
Suzano - São Paulo
CEP: 08613-010
C.N.P.J. 02.685.377/0008-23
® Marca Registrada.
Segundo fórmula original de Grupo Aventis
Frankfurt am Main – Alemanha
Atendimento ao Consumidor: 0800-7030014
C.N.P.J. 02.685.377/0001-57
Número do lote - Data de fabricação - Vencimento: vide cartucho.
Referências bibliográficas:
R. Genthon: Study of the efficacy and safety of the combination ramipril 2.5 mg plus hydrochlorothiazide 12.5 mg in patients with mild-to-moderate hypertension: ATHES Study Group. Int J Clin Pharm Res 1994; 14:1-9.
D. Heidbreder, Froer KL, Bauer B et al: Combination of ramipril and hydrochlorothiazide in the treatment of mild to moderate hypertension-Part 2: an open long-term study of efficacy and safety. Clin Cardiol 1993; 16:47-52.
D. Heidbreder, Froer KL, Breitstadt A et al: Combination of ramipril and hydrochlorothiazide in the treatment of mild to moderate hypertension: part 1--a double-blind, comparative, multicenter study in nonresponders to ramipril monotherapy. Clin Cardiol1992; 15:904-910.
J. Scholze, Breitstadt A, Cairns V et al: Short report: Ramipril and hydrochlorothiazide combination therapy in hypertension: a clinical trial of factorial design. J Hypertens 1993; 11:217-221.